Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited
Sharon E. Frey, Johannes B. Goll, John H. Beigel
Abstract
ents of the bivalent vaccine as compared with recipients of the monovalent vaccine.The evaluated events included ischemic stroke (hazard ratio, 0.86; 95% confidence interval [CI], 0.58 to 1.27), hemorrhagic stroke (hazard ratio, 0.86; 95% CI, 0.46 to 1.61), myocardial infarction (hazard ratio, 0.92; 95% CI, 0.62 to 1.36), pulmonary embolism (hazard ratio, 0.83; 95% CI, 0.49 to 1.40), and all four events combined (hazard ratio, 0.87; 95% CI, 0.69 to 1.09) (Table 1).Thus, our results provide reassurance regarding the continued use of this bivalent vaccine.
Topics & Concepts
Hazard ratioMedicineConfidence intervalMyocardial infarctionInternal medicineVaccinationSurgeryImmunologyPoxvirus research and outbreaksInfluenza Virus Research StudiesImmunotherapy and Immune Responses